|
Elisabeth Heath, MD
Phone: 410-955-8964
Arlene Forastiere, MD
Phone: 410-955-8964
|
|
|
There are two oncologists
at Johns Hopkins specializing in the care of high-grade dysplasia and
cancer of the esophagus. Dr. Elisabeth I. Heath
and Dr. Arlene A. Forastiere. They are both Board Certified in Internal Medicine and Medical
Oncology and are participating in trials involving treatment of esophageal
cancer and high-grade dysplasia in Barrett's esophagus.
Dr. Heath
is an attending medical oncologist. She received her M.D. degree from
Jefferson Medical College and completed her internal medicine training
at Georgetown University Hospital and subsequently trained in Medical
Oncology at Johns Hopkins. Her primary interest is in developing and
conducting clinical trials utilizing novel agents for patients with
cancers of the esophagus and lung. She also has an interest in chemoprevention
and has been instrumental in the design and leadership of a multi-center
cancer prevention trial for patients with Barrett's esophagus.
Dr.
Forastiere is a Professor of Medical Oncology who has served on the
Johns Hopkins medical staff for over ten years. She has participated
in numerous clinical trials involving esophageal cancer and is an author
on numerous scholarly publications in this area. Drs. Forastiere and
Heath initiated the proposal for the cyclooxegynase-2 inhibitor trial
in Barrett's esophagus patients that is now ongoing. The objective of
the trial is to prevent esophageal cancer since its incidence is increasing
at an alarming rate in the United States. They have done this in collaboration
with the Gastroenterologists and with the Johns Hopkins School of Hygiene
and Public Health and has received peer-reviewed funding for approximately
5 million dollars.
|
